(Q36678132)

15 August 2017

Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists (English)

1 reference

15 August 2017

Meredith B. Rosenthal

object named as

Meredith B Rosenthal

5

0 references

author name string

Rena M Conti

1

1 reference

15 August 2017

Arielle C Bernstein

2

1 reference

15 August 2017

Victoria M Villaflor

3

1 reference

15 August 2017

Richard L Schilsky

4

1 reference

15 August 2017

Peter B Bach

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

19 February 2013

1 reference

Journal of Clinical Oncology

15 August 2017

1 reference

15 August 2017

31

1 reference

15 August 2017

9

1 reference

15 August 2017

1134-1139

1 reference

White Paper: Potential Conflict of Interest in the Production of Drug Compendia

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatments.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Decline in the use of anthracyclines for breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Projecting future drug expenditures--2012.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Prioritizing future research on off-label prescribing: results of a quantitative evaluation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Off-label use of anticancer drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Off-label prescribing among office-based physicians

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

The quality of antipsychotic drug prescribing in nursing homes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

The price tag on progress--chemotherapy for colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Overuse of proton pump inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Self-reported practices and attitudes of US oncologists regarding off-protocol therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Reimbursement Policies Constrain the Practice of Oncology

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Off-label use of rituximab in a multipayer insurance system.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Adoption of intensity-modulated radiation therapy for breast cancer in the United States

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Targeted therapy for advanced colorectal cancer--more is not always better

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Prescription drug spending trends in the United States: looking beyond the turning point

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Cost of care for elderly cancer patients in the United States.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

The quality of pharmacologic care for adults in the United States

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Do oncologists believe new cancer drugs offer good value?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Inappropriate medication prescribing for elderly ambulatory care patients

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3595423

Limits on Medicare's ability to control rising spending on cancer drugs

5 September 2018

1 reference

12 December 2020

Reimbursement for cancer treatment: coverage of off-label drug indications

1 reference

12 December 2020

Recent Developments in Medicare Coverage of Off-Label Cancer Therapies

1 reference

12 December 2020

ASCO supports government report: "Off-label drugs: reimbursement policies constrain physicians in choice of cancer therapies"

1 reference

12 December 2020

Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer

1 reference

12 December 2020

The Urgent Need to Improve Health Care Quality Institute of Medicine National Roundtable on Health Care Quality

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2012.42.7252

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23423747

1 reference